News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
石四藥(02005.HK)與龍海藥業就四款生物類似藥合作簽意向書
石四藥(02005.HK)公布，於6月5日(今日)，全資附屬石家莊四藥已與龍海藥業就有關烏司奴單抗、度普利尤單抗、阿柏西普注射液以及依洛尤單抗共四款生物類似藥的潛在合作簽訂一份意向書。(ha/da)~阿思達克財經新聞網址: www.aastocks.com
Reset
Send
The window will close in 5 seconds
石四藥(02005.HK)與龍海藥業就四款生物類似藥合作簽意向書
Close
Recommend
3
Positive
1
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

石四藥(02005.HK)  -0.060 (-2.542%)    Short selling $3.46M; Ratio 35.523%   公布，於6月5日(今日)，全資附屬石家莊四藥已與龍海藥業就有關烏司奴單抗、度普利尤單抗、阿柏西普注射液以及依洛尤單抗共四款生物類似藥的潛在合作簽訂一份意向書。(ha/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-08 16:25.)

Switch to Auto-Translated Version
AASTOCKS新聞
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.